STRATEGIC CONSULTING
Offering business decision support, growth strategy, market access strategy, and business development and licensing services for life science companies
Growth Strategy
Differentiating strategies for life science companies: large, medium–sized, and biotech
We help our clients devise winning strategies and focus their efforts.
In a highly regulated industry such as the life sciences, developing the right product for patients is critical to ensure business sustainability. Our strategic consulting services include competitive market analysis, potential assessment, and go-to-market strategy. We tailor our solutions to the needs of our clients: for example, we have a specific offering for biotech companies, ensuring they get answers to their most pressing questions with methodologies suited to their budget.
ProductLife Consulting’s Added Value
In market and potential assessment, we bring the specialist approach of life science consultants together with the expertise and the implications of different clinical development programs regarding costs and risks – dimensions that traditional consulting companies tend to struggle with.
We tailor our approach to our clients’ profiles and can offer focused and quick turnaround services as necessary to meet our clients’ budgets and needs.
An early-stage biotech and a large pharma have different expectations regarding strategic decision support. Our team is equally comfortable working on longer timelines with large research samples or answering key targeted questions with a fit-for-purpose methodology.
Jean-Luc Taborin
EVP, Head of ProductLife Consulting
Strategic Market Access
Pricing and reimbursement perspective integrated with product development
As health systems evolve and budgets become tighter, ensuring clarity on product value proposition, future potential price levels, and reimbursement conditions is essential for patients to access medicines. We offer strategic advice on market access questions, generating insight through internal expertise, advisory boards, and market research.
We offer support from early clinical development to help clarify and stress test your product’s value proposition and make an early estimate of future potential price and reimbursement conditions in key countries. Along the development process, we offer support in re-assessing the strategy and helping identify the critical data to collect for market access purposes.
Why choose ProductLife Consulting to define your market access strategy?
We can integrate market access with the rest of the product development activities and effectively plan to make the most of the data for market authorization, pricing, and reimbursement.
Our footprint in 196 countries ensures we can access data and research in leading markets and smaller geographies.
Our offering includes medicines, innovative therapeutics such as digital therapeutics (DTx), and medical devices.
Business Development and Licensing
Life science specialists with broader technical expertise to support robust assessments and integrations
We offer dedicated consulting services to support life science companies and investors in their investment and external growth activities. From target screening to due diligence (commercial, manufacturing, and regulatory) and post-merger integration support, our clients recognize the need for specific life science expertise.
We have conducted due diligence work on behalf of private equity funds, pharma, CROs, and other pharma services companies, and we can offer commercial due diligence (including access due diligence), manufacturing, and regulatory focus, combined or separately, as per our clients’ needs
ProductLife Consulting’s Added Value
We offer the full scope of life science expertise, including regulatory, manufacturing, and commercial assessment expertise.
Our consultants have hands-on expertise in mergers and acquisitions (M&A)
After advising on M&A, I got to experience it from the inside when I joined The Economist Group following their acquisition of two consultancies focused on life science. I lived through the concepts and hurdles I previously only discussed in meeting rooms.
Dr. Annie Jullien Pannelay
Partner
